Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
clinical trials
3
×
life sciences
national blog main
alirocumab
alnylam pharmaceuticals
amgen
boston blog main
evolocumab
fda
inclisiran
new york
new york blog main
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
bempedoic acid
boston top stories
cholesterol
corticosteroids
deals
detroit
detroit blog main
detroit top stories
drugs
esperion therapeutics
evercore isi
ezetimibe
fluoroquinolones
heart attack
joseph swartz
medicines co.
national top stories
novartis
pcsk9
sanofi
statins
stroke
svb leerink
What
cholesterol
3
×
drug
medicines
fda
lowering
medco
new
acquire
agreed
alnylam
approved
based
billion
brings
cash
combo
company
compound
data
deal
esperion
esperion’s
evidence
heart
lasting
levels
long
looms
nod
novartis
pairs
partner
pharmaceuticals
pill
poised
presented
ready
reckoning
regulatory
rna
Language
unset
Current search:
biotech
×
" clinical trials "
×
cholesterol
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms